Insights From the ESMO Congress

Dr Joshua Richter, Associate Professor of Medicine, Tisch Cancer Institute

Videos

Analyzing the Effect of Immune Therapies on Infection in Patients With Multiple Myeloma

12/05/2022

Dr Joshua Richter, associate professor of medicine at Tisch Cancer Institute, discusses his presentation on the effects of immune therapies on infection in patients with multiple myeloma.

Dr Joshua Richter, associate...

12/05/2022

Journal of Clinical Pathways

News

Evolution of Diagnosis and Treatment of SCLC Over the Last 20 Years

10/22/2021

Marta Rybczynski ;

Study findings suggest that changes in the clinical management of patients with SCLC over the last 20 years have not had a significant impact on survival.

Study findings suggest that...

10/22/2021

Journal of Clinical Pathways

Videos

Real-World Outcomes of HR-Positive HER2-Negative Metastatic Breast Cancer Treated With ICIs

10/21/2021

Ethan Sokol, PhD, discusses real-world time-to-treatment-discontinuation for patients with high tumor mutational burden HR-positive and HER2-negative breast cancer who were treated with immune checkpoint inhibitors.

Ethan Sokol, PhD, discusses...

10/21/2021

Journal of Clinical Pathways

Videos

Real-World Testing and Treatment Patterns in Advanced NSCLC

10/18/2021

Geoffrey Oxnard, MD, compares treatment regimens for patients with advanced NSCLC prior to receipt of comprehensive genomic profiling vs after receipt of comprehensive genomic profiling in the real-world setting.

Geoffrey Oxnard, MD, compares...

10/18/2021

Journal of Clinical Pathways

Videos

Physician Survey Reveals Key Attributes for Third-Line Treatment Selection for DLBCL

10/18/2021

Patrick Connor Johnson, MD, discusses study results on physician perspectives regarding key attributes for selecting third-line treatment for DLBCL.

Patrick Connor Johnson, MD,...

10/18/2021

Journal of Clinical Pathways

Videos

Real-World Utilization of Advanced Therapies Among Patients With Metastatic CSPC

10/07/2021

Daniel George, MD, discusses results from a study analyzing real-world utilization of advanced therapies for patients with metastatic CSPC over time by metastatic site and age.

Daniel George, MD, discusses...

10/07/2021

Journal of Clinical Pathways

Videos

Real-World Adoption and Outcomes of Atezolizumab Plus Carboplatin and Etoposide for Extensive-Stage SCLC

10/04/2021

David Chun Cheong Tsui, MD, discusses results from a real-world study exploring the adoption and early clinical outcomes of atezolizumab plus carboplatin and etoposide in patients with extensive-stage SCLC.

David Chun Cheong Tsui, MD,...

10/04/2021

Journal of Clinical Pathways

Insights From the ESMO Congress

Specialties

Events

Year Round Education

HMP Global Products